Epogen, Aranesp, and Procrit Get Stronger Warnings

Two pharmaceutical companies, Johnson & Johnson and Amgen, have agreed to place stronger warning labels on three anemia drugs. The decision was made in consulation with the FDA after studies have shown that Epogen, Aranesp, and Procrit all could cause heart attacks, a worsening of cancer, and death. The drugs are used by approximately 1 million cancer patients a year.